Fabris N
Experientia. 1981; 37(10):1041-3.
PMID: 7308382
DOI: 10.1007/BF02085001.
Shaw S, Duquesnoy R, Smith P
Immunogenetics. 1981; 14(1-2):153-62.
PMID: 6976932
DOI: 10.1007/BF00344308.
Sredni B, Volkman D, Schwartz R, Fauci A
Proc Natl Acad Sci U S A. 1981; 78(3):1858-62.
PMID: 6972044
PMC: 319234.
DOI: 10.1073/pnas.78.3.1858.
Reiss C, Hemler M, Englehard V, Mier J, Strominger J, Burakoff S
Proc Natl Acad Sci U S A. 1980; 77(9):5432-6.
PMID: 6968913
PMC: 350073.
DOI: 10.1073/pnas.77.9.5432.
Zeevi A, Annen K, Scheffel C, Duquesnoy R
Immunogenetics. 1983; 18(3):205-20.
PMID: 6604694
DOI: 10.1007/BF00952960.
Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes.
Zarling J, Kay N, Grant B, Yasukawa M, Bach F
Cancer Immunol Immunother. 1983; 15(3):237-9.
PMID: 6604571
PMC: 11039179.
DOI: 10.1007/BF00199171.
Surface markers of cloned human alloreactive T lymphocytes.
Chardonnens X, Froment Y, Joye M, Jeannet M
Immunogenetics. 1982; 15(3):327-30.
PMID: 6461594
DOI: 10.1007/BF00364341.
Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
Pawelec G, Rehbein A, Muller C, Sonneborn H, Wernet P
Immunology. 1981; 42(4):529-40.
PMID: 6453828
PMC: 1458274.
Retention of specific proliferative capacity of cloned human T cells alloactivated against HLA-D alleles.
Pawelec G, Rehbein A, Alter B, Wernet P
Immunogenetics. 1980; 11(5):527-32.
PMID: 6242887
DOI: 10.1007/BF01567821.
Restimulation properties of human alloreactive cloned T-cell lines. Dissection of HLA-D-region alleles in population studies and in family segregation analysis.
Pawelec G, Wernet P
Immunogenetics. 1980; 11(5):507-19.
PMID: 6242886
DOI: 10.1007/BF01567819.
Dw/LD-related molecular polymorphism of DR4 beta-chains.
Groner J, Watson A, Bach F
J Exp Med. 1983; 157(5):1687-91.
PMID: 6189945
PMC: 2187006.
DOI: 10.1084/jem.157.5.1687.
Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
Zeevi A, Scheffel C, Annen K, Bass G, Marrari M, Duquesnoy R
Immunogenetics. 1982; 16(3):209-18.
PMID: 6183198
DOI: 10.1007/BF00343310.
Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.
Eckels D, Hartzman R
Immunogenetics. 1982; 16(2):117-33.
PMID: 6183195
DOI: 10.1007/BF00364399.
T cell clones: their use for the study of specificity, induction, and effector-function of T cells.
von Boehmer H, Haas W, Pohlit H, Hengartner H, Nabholz M
Springer Semin Immunopathol. 1980; 3(1):23-37.
PMID: 6169167
DOI: 10.1007/BF00199924.
Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation.
Kimoto M, Fathman C
J Exp Med. 1980; 152(4):759-70.
PMID: 6158548
PMC: 2185955.
DOI: 10.1084/jem.152.4.759.
Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.
Rosen-Bronson S, Johnson A, Hartzman R, Eckels D
Immunogenetics. 1986; 24(5):286-97.
PMID: 3491043
DOI: 10.1007/BF00395533.
Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.
Kikuchi Y, Kita T, Oomori K, Miyauchi M, Iwano I, Kizawa I
Med Oncol Tumor Pharmacother. 1988; 5(2):85-90.
PMID: 3137397
DOI: 10.1007/BF02985443.
Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. I. Growth and specificity analysis.
Rosen-Bronson S, Johnson A, Hartzman R, Eckels D
Immunogenetics. 1986; 23(6):368-78.
PMID: 2941363
DOI: 10.1007/BF00372669.
Proliferative and cytotoxic responses of human peripheral blood lymphocytes to autologous malignant effusions. An analysis at the clonal level.
Roberts T, Shipton U, Moore M
Cancer Immunol Immunother. 1986; 22(2):107-13.
PMID: 2941144
PMC: 11041102.
DOI: 10.1007/BF00199123.
Recognition of class II molecules by human T cells. I. Analysis of epitopes of DR and DQ molecules in a DRw11, DRw52, DQw3 haplotype.
Myers L, Ball E, Nunez G, Stastny P
Immunogenetics. 1986; 23(3):142-50.
PMID: 2420717
DOI: 10.1007/BF00373814.
